| Date |
Report No. |
Title |
| Date Oct. 4, 2011 |
Report No. GAO-12-104T |
Title
United States Government Accountability Office GAO
For Release on Delivery Expected at 10:30 a.m. EDT Tuesday, October 4, 2011 Testimony
Before the Subcommittee on Federal Financial Management, Government Information, Federal Services, and International Security, Committee on Homeland Security and Governmental Affairs, U.S. Senate MEDICARE PART D Instances of Questionable Access to Prescription Dr... |
| Date Sept. 6, 2011 |
Report No. GAO-11-699 |
Title
United States Government Accountability Office GAO
September 2011 Report to Congressional Requesters MEDICARE PART D Instances of Questionable Access to Prescription Drugs GAO-11-699 September 2011 MEDICARE PART D
Instances of Questionable Access to Prescription Drugs
Highlights of GAO-11-699, a report to congressional requesters Why GAO Did This Study
In 2009, GAO reported on doctor shopping in M... |
| Date Aug. 26, 2011 |
Report No. GAO-11-744 |
Title
United States Government Accountability Office GAO
August 2011 Report to Congressional Requesters PRESCRIPTION DRUG CONTROL DEA Has Enhanced Efforts to Combat Diversion, but Could Better Assess and Report Program Results GAO-11-744 August 2011 PRESCRIPTION DRUG CONTROL
DEA Has Enhanced Efforts to Combat Diversion, but Could Better Assess and Report Program Results
Highlights of GAO-11-744, a repor... |
| Date July 28, 2011 |
Report No. GAO-11-763 |
Title
United States Government Accountability Office GAO
July 2011 Report to Congressional Requesters COMBATTING ILLICIT DRUGS DEA and ICE Interagency Agreement Has Helped to Ensure Better Coordination of Drug Investigations GAO-11-763 July 2011 COMBATTING ILLICIT DRUGS
DEA and ICE Interagency Agreement Has Helped to Ensure Better Coordination of Drug Investigations
Highlights of GAO-11-763, a report to... |
| Date May 2, 2011 |
Report No. GAO-11-261R |
Title
United States Government Accountability Office Washington, DC 20548 May 2, 2011 Congressional Committees Subject: Office of National Drug Control Policy: Agencies View the Budget Process as Useful for Identifying Priorities, but Challenges Exist Illicit drug use endangers public health and safety and depletes financial resources. According to the Office of National Drug Control Policy (ONDCP), eac... |
| Date July 21, 2010 |
Report No. GAO-10-921T |
Title
United States Government Accountability Office GAO
For Release on Delivery Expected at 10:00 a.m. EDT Wednesday, July 21, 2010 Testimony Before the Subcommittee on Domestic Policy, Committee on Oversight and Government Reform, House of Representatives DRUG CONTROL International Programs Face Significant Challenges Reducing the Supply of Illegal Drugs but Support Broad U.S. Foreign Policy Objective... |
| Date Sept. 30, 2009 |
Report No. GAO-09-1004T |
Title
United States Government Accountability Office GAO
For Release on Delivery Expected at 3:00 p.m. EDT Wednesday, September 30, 2009 Testimony before the Subcommittee on Federal Financial Management, Government Information, Federal Services, and International Security, Committee on Homeland Security and Governmental Affairs, U.S. Senate MEDICAID Fraud and Abuse Related to Controlled Substances Ident... |
| Date Sept. 9, 2009 |
Report No. GAO-09-957 |
Title
United States Government Accountability Office GAO
September 2009 Report to Congressional Requesters MEDICAID Fraud and Abuse Related to Controlled Substances Identified in Selected States GAO-09-957 September 2009 MEDICAID Highlights
Highlights of GAO-09-957, a report to congressional requesters Accountability Integrity Reliability Fraud and Abuse Related to Controlled Substances Identified in Se... |
| Date July 20, 2009 |
Report No. GAO-09-806 |
Title
United States Government Accountability Office GAO
July 2009 Report to the Ranking Member, Committee on Foreign Relations, U.S. Senate DRUG CONTROL U.S. Counternarcotics Cooperation with Venezuela Has Declined GAO-09-806 July 2009 DRUG CONTROL Highlights
Highlights of GAO-09-806, a report to the Ranking Member, Committee on Foreign Relations, U.S. Senate Accountability Integrity Reliability U.S. C... |
| Date March 26, 2009 |
Report No. GAO-09-341 |
Title
United States Government Accountability Office GAO
March 2009 Report to Congressional Requesters METHADONEASSOCIATED OVERDOSE DEATHS Factors Contributing to Increased Deaths and Efforts to Prevent Them GAO-09-341 March 2009 Highlights
Highlights of GAO-09-341, a report to congressional requesters Accountability Integrity Reliability METHADONE-ASSOCIATED OVERDOSE DEATHS
Factors Contributing to Incr... |
| Date March 20, 2009 |
Report No. GAO-09-63 |
Title
United States Government Accountability Office GAO
March 2009 Report to the Co-Chairman, Caucus on International Narcotics Control, U.S. Senate DRUG CONTROL Better Coordination with the Department of Homeland Security and an Updated Accountability Framework Can Further Enhance DEA’s Efforts to Meet Post-9/11 Responsibilities GAO-09-63 March 2009 DRUG CONTROL Highlights
Highlights of GAO-09-63, a... |
| Date Oct. 6, 2008 |
Report No. GAO-09-71 |
Title
United States Government Accountability Office GAO
October 2008 Report to the Honorable Joseph R. Biden, Jr., Chairman, Committee on Foreign Relations, U.S. Senate PLAN COLOMBIA Drug Reduction Goals Were Not Fully Met, but Security Has Improved; U.S. Agencies Need More Detailed Plans for Reducing Assistance GAO-09-71 October 2008 PLAN COLOMBIA Highlights
Highlights of GAO-09-71, a report to the Ho... |
| Date July 15, 2008 |
Report No. GAO-08-784 |
Title
United States Government Accountability Office GAO
July 2008 Report to Congressional Requesters DRUG CONTROL Cooperation with Many Major Drug Transit Countries Has Improved, but Better Performance Reporting and Sustainability Plans Are Needed GAO-08-784 July 2008 DRUG CONTROL Highlights
Highlights of GAO-08-784, a report to congressional requesters Accountability Integrity Reliability Cooperation ... |
| Date June 30, 2008 |
Report No. GAO-08-829R |
Title
United States Government Accountability Office Washington, DC 20548 June 30, 2008 The Honorable James L. Oberstar Chairman Committee on Transportation and Infrastructure House of Representatives The Honorable Peter A. DeFazio Chairman Subcommittee on Highways and Transit Committee on Transportation and Infrastructure House of Representative Subject: Examples of Job Hopping by Commercial Drivers af... |
| Date Aug. 25, 2006 |
Report No. GAO-06-818 |
Title
United States Government Accountability Office GAO
August 2006 Report to the Subcommittee on Transportation, Treasury, the Judiciary, Housing and Urban Development, and Related Agencies, Committee on Appropriations, U.S. Senate ONDCP MEDIA CAMPAIGN Contractor’s National Evaluation Did Not Find That the Youth Anti-Drug Media Campaign Was Effective in Reducing Youth Drug Use GAO-06-818 August 2006... |
| Date Dec. 13, 2005 |
Report No. GAO-06-175T |
Title
United States Government Accountability Office GAO
For Release on Delivery Expected at 1:00 p.m. EST Tuesday, December 13, 2005 Testimony Before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, U.S. House of Representatives PRESCRIPTION DRUGS Enhanced Efforts and Better Agency Coordination Needed to Address Illegal Importation
Statement of Richard M. Stana, Direc... |
| Date Nov. 15, 2005 |
Report No. GAO-06-200 |
Title
United States Government Accountability Office GAO
November 2005 Report to Congressional Committees DRUG CONTROL Agencies Need to Plan for Likely Declines in Drug Interdiction Assets, and Develop Better Performance Measures for Transit Zone Operations GAO-06-200 a November 2005 DRUG CONTROL Highlights
Highlights of GAO-06-200, a report to congressional committees Accountability Integrity Reliabili... |
| Date Nov. 3, 2005 |
Report No. GAO-06-243R |
Title
United States Government Accountability Office Washington, DC 20548 November 3, 2005 The Honorable Tom Davis Chairman The Honorable Henry Waxman Ranking Minority Member Committee on Government Reform House of Representatives Subject: Anabolic Steroids Are Easily Purchased Without a Prescription and Present Significant Challenges to Law Enforcement Officials This report responds to your request tha... |
| Date Sept. 8, 2005 |
Report No. GAO-05-372 |
Title
United States Government Accountability Office GAO
September 2005 Report to Congressional Requesters PRESCRIPTION DRUGS Strategic Framework Would Promote Accountability and Enhance Efforts to Enforce the Prohibitions on Personal Importation GAO-05-372 September 2005 PRESCRIPTION DRUGS Highlights
Highlights of GAO-05-372, a report to congressional requesters Accountability Integrity Reliability Str... |
| Date May 17, 2005 |
Report No. GAO-05-653T |
Title
United States Government Accountability Office GAO
For Release on Delivery Expected at 9:30 a.m. EDT Tuesday, May 17, 2005 Testimony Before the Chairman, Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives DRUG TESTS Products to Defraud Drug Use Screening Tests Are Widely Available
Statement of Robert J. Cramer, Managing Director Office of Speci... |
| Date July 29, 2004 |
Report No. GAO-04-918 |
Title
United States Government Accountability Office GAO
July 2004 Report to the Honorable Charles E. Grassley, Chairman, Caucus on International Narcotics Control, U.S. Senate DRUG CONTROL Aviation Program Safety Concerns in Colombia Are Being Addressed, but State’s Planning and Budgeting Process Can Be Improved GAO-04-918 a July 2004 DRUG CONTROL Aviation Program Safety Concerns in Colombia Are Bein... |
| Date July 22, 2004 |
Report No. GAO-04-839T |
Title
United States Government Accountability Office GAO
For Release on Delivery Expected at 9:00 a.m. EDT Thursday, July 22, 2004 Testimony Before the Permanent Subcommittee on Investigations, Committee on Governmental Affairs, U.S. Senate PRESCRIPTION DRUGS Preliminary Observations on Efforts to Enforce the Prohibitions on Personal Importation
Statement of Richard M. Stana, Director Homeland Security ... |
| Date April 22, 2004 |
Report No. GAO-04-490 |
Title
United States General Accounting Office GAO
April 2004 Report to Congressional Requesters ANTIBIOTIC RESISTANCE Federal Agencies Need to Better Focus Efforts to Address Risk to Humans from Antibiotic Use in Animals GAO-04-490 a April 2004 ANTIBIOTIC RESISTANCE Federal Agencies Need to Better Focus Efforts to Address Risk to Humans from Antibiotic Use in Animals Highlights of GAO-04-490, a report t... |
| Date March 4, 2004 |
Report No. GAO-04-524T |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 1:00 p.m. EST Thursday, March 4, 2004 Testimony Before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives PRESCRIPTION DRUGS State Monitoring Programs May Help to Reduce Illegal Diversion
Statement of Marcia Crosse Director, Health Care—Public Health and Military Health Care Issues... |
| Date Dec. 19, 2003 |
Report No. GAO-04-110 |
Title
United States General Accounting Office GAO
December 2003 Report to Congressional Requesters PRESCRIPTION DRUGS OxyContin Abuse and Diversion and Efforts to Address the Problem GAO-04-110 December 2003 PRESCRIPTION DRUGS OxyContin Abuse and Diversion and Efforts to Address the Problem Highlights of GAO-04-110, a report to congressional requesters Amid heightened awareness that many patients with c... |
| Date June 3, 2003 |
Report No. GAO-03-820T |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 9:30 a.m. EDT Tuesday, June 3, 2003 Testimony Before the Caucus on International Narcotics Control, U.S. Senate DRUG CONTROL Financial and Management Challenges Continue to Complicate Efforts to Reduce Illicit Drug Activities in Colombia
Statement of Jess T. Ford, Director International Affairs and Trade GAO-03-820T Ju... |
| Date Jan. 15, 2003 |
Report No. GAO-03-172R |
Title
United States General Accounting Office Washington, DC 20548 January 15, 2003 The Honorable Richard J. Durbin United States Senate Subject: Youth Illicit Drug Use Prevention: DARE Long-Term Evaluations and Federal Efforts to Identify Effective Programs Dear Senator Durbin: The use of illicit drugs, particularly marijuana, is a problem among our nation’s youth. The adverse effects of illicit drug... |
| Date Jan. 8, 2003 |
Report No. GAO-03-319R |
Title
United States General Accounting Office Washington, DC 20548 January 8, 2003 The Honorable Charles H. Taylor House of Representatives Subject: Drug Control: Coca Cultivation and Eradication Estimates in Colombia Dear Mr. Taylor: Colombia is the world’s leading producer and distributor of cocaine and a significant supplier of heroin to the United States. According to the Department of State, Colo... |
| Date Jan. 1, 2003 |
Report No. GAO-03-107 |
Title
United States General Accounting Office GAO
January 2003 Performance and Accountability Series Major Management Challenges and Program Risks Department of State GAO-03-107 a A Glance at the Agency Covered in This Report
To carry out U.S. foreign policy, the Department of State
G formulates U.S. policy on numerous international issues and influences other countries to adopt policies and practices c... |
| Date Nov. 1, 2002 |
Report No. GAO-03-189 |
Title
United States General Accounting Office GAO
November 2002 Report to the Chairman, Subcommittee on Criminal Justice, Drug Policy and Human Resources, Committee on Government Reform, U.S. House of Representatives MARIJUANA Early Experiences with Four States’ Laws That Allow Use for Medical Purposes GAO-03-189 Contents Letter
Results in Brief Background Implementation in Oregon, Alaska, Hawaii, and... |
| Date May 17, 2002 |
Report No. GAO-02-634 |
Title
United States General Accounting Office GAO
May 2002 Report to the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives PRESCRIPTION DRUGS State Monitoring Programs Provide Useful Tool to Reduce Diversion GAO-02-634 Contents Letter
Results in Brief Background PDMPs Vary in Objectives, Design, and Operation State Programs Have Helped Shorten Inves... |
| Date Feb. 13, 2002 |
Report No. GAO-02-276R |
Title
United States General Accounting Office Washington, DC 20548 February 13, 2002 The Honorable Jeff Sessions United States Senate Subject: The Drug Enforcement Administration’s Reporting of Arrests Dear Senator Sessions: The mission of the Drug Enforcement Administration (DEA) is to enforce U.S. laws and regulations regarding controlled substances and to help bring to justice those involved in gro... |
| Date Sept. 14, 2001 |
Report No. GAO-01-1011 |
Title
United States General Accounting Office GAO
September 2001 Report to Congressional Requesters ATTENTION DISORDER DRUGS Few Incidents of Diversion or Abuse Identified by Schools GAO-01-1011 Contents Letter
Results in Brief Background Few Incidents of Diversion or Abuse of Attention Disorder Drugs Identified by Schools Most Schools Dispense Attention Disorder Medications and Follow Drug Security Pro... |
| Date Jan. 19, 2001 |
Report No. GAO-01-286R |
Title
United States General Accounting Office Washington, DC 20548 January 19, 2001 The Honorable Tom Harkin The Honorable Olympia J. Snowe The Honorable Barbara A. Mikulski United States Senate The Honorable Henry A. Waxman House of Representatives Subject: Drug Safety: Most Drugs Withdrawn in Recent Years Had Greater Health Risks for Women The Food and Drug Administration (FDA) approves drugs for sale... |
| Date Dec. 2, 1999 |
Report No. AIMD-00-34R |
Title
F 4 -*MCWr*IYbllY
OiBce United States General Accounting washiagton, DC 20648 Accounting and hfommation
Management Divisiom B-284009 December 2,1999 The Honorable Janet Reno The Attorney General Subject: FBI Accountabilitv for Drugs Used in SD&al Oomons: Deficiencies Idenmed and Actions Taken Dear Madam Attorney General: 1990, GAO has periodically reported on government operations that we have ide... |
| Date Aug. 26, 1999 |
Report No. NSIAD/OSI-99-133 |
Title
United States General Accounting Office GAO
August 1999 Report to the Secretary of Defense, the Attorney General, and the Secretary of the Treasury DEPARTMENT OF DEFENSE Military Assistance Provided at Branch Davidian Incident GAO/NSIAD/OSI-99-133 United States General Accounting Office Washington, D.C. 20548 National Security and International Affairs Division B-276428 Letter August 26, 1999 The ... |
| Date Sept. 3, 1998 |
Report No. GGD-98-188 |
Title
United States General Accounting Office GAO
September 1998 Report to the Chairman, Caucus on International Narcotics Control, U.S. Senate DRUG CONTROL Information on High Intensity Drug Trafficking Areas Program GAO/GGD-98-188 GAO United States General Accounting Office Washington, D.C. 20548 General Government Division B-277402 September 3, 1998 The Honorable Charles E. Grassley Chairman, Caucus ... |
| Date July 20, 1998 |
Report No. HEHS-98-130 |
Title
United States General Accounting Office GAO
July 1998 Report to the Honorable Daniel Patrick Moynihan and the Honorable James M. Jeffords, U.S. Senate EMERGING DRUG PROBLEMS Despite Changes in Detection and Response Capability, Concerns Remain GAO/HEHS-98-130 GAO United States General Accounting Office Washington, D.C. 20548 Health, Education, and Human Services Division B-277159 July 20, 1998 The... |
| Date Sept. 12, 1996 |
Report No. T-NSIAD-96-239 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 10:00 a.m., EDT Thursday September 12, 1996 Testimony
Before the Subcommittee on Coast Guard and Maritime Transportation, Committee on Transportation and Infrastructure, House of Representatives and the Caucus on International Narcotics Control, U.S. Senate DRUG CONTROL Observations on Counternarcotics Activities in Me... |
| Date Aug. 24, 1995 |
Report No. PEMD-95-12 |
Title
United States General Accounting Office GAO
August 1995 Report to the Ranking Minority Member, Committee on Commerce, House of Representatives NONPRESCRIPTION DRUGS Value of a PharmacistControlled Class Has Yet to Be Demonstrated GAO/PEMD-95-12 GAO United States General Accounting Office Washington, D.C. 20548 Program Evaluation and Methodology Division B-252141 August 24, 1995 The Honorable John ... |
| Date Aug. 1, 1995 |
Report No. T-NSIAD-95-194 |
Title
United States General Accounting Offke GAO
For Release on Delivery Expected at 1090 a.m., EDT, Tuesday, August 1, 1995 Testimony
Before the Subcommittee on Coast Guard and Maritime Transportation, Committee on Transportation and Infrastructure, House of Representatives DRUG WAR Observations on U.S. International Drug Control
Efforts
Statement of Joseph E. Kelley, Director-in-Charge International A... |
| Date July 31, 1995 |
Report No. HEHS-95-179R |
Title
(3AO United States General Accounting Office
Washington, D.C. 20548 Health, Education and Human Services Division B-261705 July 31, 1995 The Honorable William F. Clinger, Jr. Chairman, Committee on Government Reform and Oversight House of Representatives The Honorable Cardiss Collins House of Representatives The Honorable Henry A. Waxman House of Representatives Illicit drug use, particularly coca... |
| Date Jan. 18, 1995 |
Report No. GGD-95-52R |
Title
GAO United States General Accounting Offke Washington, D.C. 20548 General Government Division B-259550 January 18, 1995 Jr. The Honorable F. James Sensenbrenner, House of Representatives Dear Mr. Sensenbrenner: This correspondence responds to your request for information on how certain controlled substances are regulated, particularly methylphenidate-a central nervous system stimulant approved for... |
| Date Aug. 2, 1994 |
Report No. NSIAD-94-233 |
Title
__- I..bjte@ l&a&es ‘ .SWes ,Ganem\ Acco~l&g Ganem\ Acco~$img Office GAO i3epw-tto the Chairinan, Subcommittee -on Worm&ion, Justice, Transportation, and Agriculture, Committee on Govemtient Opertitions, House of Representatives GAO/NSIAD-94-&M United States General Accounting Office Washington, D.C. 20648 National Security and International Affairs Division B-257824 August 2, 1994 The Honorable... |
| Date Aug. 2, 1994 |
Report No. T-NSIAD-94-251 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at IO:00 a.m. EDT, Tuesday August 2, 1994 Testimony
Before the Subcommittee on Information, Justice, Transportation, and Agriculture, Committee on Government Operations, House of Representatives DRUG CONTROL U.S. Counterdrug Activities in Central America
Statement of Benjamin F. Nelson, Associate Director, International A... |
| Date Dec. 29, 1993 |
Report No. HRD-94-24 |
Title
United States General Accounting Offke /row GAO
December 1YY)Y Report to the Chairman, Subcommittee on Children, Family, Drugs, and Aicoholisin, Committee on Labor and Human Resources, U.S. Senate DRUG USE AMONG YOUTH No Simple Answers to Guide Prevention GAO/HRD-94-24 Notice: This is a reprint of a GAO report. United States General Accounting Office Washington, D.C. 20548 Human Resources Division... |
| Date Nov. 15, 1993 |
Report No. T-GGD-94-49 |
Title
United StatesGeneralAccounting Offwze GAO
For Releaseon Delivery Expectedat November 15, 1993 2:OO p.m. Testimony
Before the Subcommittee on Treasury, Postal Service, and General Government Committee on Appropriations House of Representatives DRUG CONTROL The Offke of National Drug Control Policy-Strategies u Need PerformanceMeasures
Statement of Henry R. Wray Director Administration of Justice Is... |
| Date Nov. 4, 1993 |
Report No. GGD-94-51R |
Title
GAO United States General Accounting Offke Washington, D.C. 20548 General Government Division B-254530 November 4, 1993 The Honorable Al McCandless Ranking Minority Member Legislation and National Security Subcommittee Committee on.Government Operations House of Representatives Dear Mr. McCandless: This letter is in response to your October 15, 1993, request for GAO's views on the question: "What ... |
| Date Oct. 5, 1993 |
Report No. T-NSIAD-94-14 |
Title
United States General Accounting Offwe GAO
For Release on Delivery Expected at 1O:oOa.m., EDT Tuesday, October 5, 1993 Testimony
Before the Legislation and National Security Subcommittee, Committee on Government Operations, House of Representatives DRUG CONTROL Expanded Military Surveillance Not Justified by Measurable Goals or Results
Statement of Louis J. Rodrigues, Director, Systems Development... |
| Date Oct. 5, 1993 |
Report No. T-GGD-94-7 |
Title
United States General Accounting Office GAO
For Releasson Delivery Expectedat October 5, 1993 1O:OO a.m. Testimony
Before the Legislation and National Security Subcommittee Committee on Government Operations House of Representatives Y DRUG CONTROL Reauthorization of the Office of National Drug Control Policy
Statement of Henry R. Wray Director Administration of Justice Issues General Government Di... |
